Department of Respiratory Medicine
Leipzig, Saxony, 04103, Germany
NCT Number: NCT02885103
This study will prove to concept of effectiveness of NHF in combination with a nebulizer on reversibility of lung function in COPD patients.
Looking for future studies?
Notify MeAll sexes
Interventional
Not applicable
Leipzig, Saxony, 04103, Germany
Patients will inhale on day 1 with a nebulizer and on another day with combination of nebulizer an NHF in a randomised order.
Healthy volunteers accepted: No
Only the study team can determine whether someone qualifies for participation.
Inclusion criteria
Exclusion criteria
NHF will be combinated with a nebulizer. Inhalation will be done on nasal cavity.
Inhalation will be done will Nebulizer and via mouth
Time frame: 45 minutes
litre
Time frame: 45 min
University of Leipzig
Other
Effect of Nasal Highflow in Combination With a Nebulizer on Reversibility in Lung Function in Patients With COPD
Acronym: AEROFLOW
OpenTrials presents study information sourced from ClinicalTrials.gov. The official registry record should be consulted for the latest information.
View the official ClinicalTrials.gov record (opens in a new tab)This listing is for discovery and informational purposes only. It is not medical advice, does not guarantee that a study is recruiting, and does not determine eligibility. Contact the study team and a qualified healthcare professional when considering participation.
Published trials that share one or more normalized conditions with this study.
NCT05984823
Chronic Disease, Chronic Obstructive Pulmonary Disease
Leicester, Leicestershire, United Kingdom
View Trial DetailsNCT05572333
COPD, Chronic Disease
Frankfurt, Germany
View Trial DetailsNCT03641235
Chronic Disease, Chronic Obstructive Pulmonary Disease
Bordeaux, France
View Trial DetailsNCT05984680
Chronic Disease, Chronic Obstructive Pulmonary Disease
Winston-Salem, North Carolina, United States
View Trial Details